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Shock Index Predicts Patient-Related Clinical Outcomes in Stroke
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Deepak L. Bhatt, MD, MPH; Gregg C. Fonarow, MD; Lee H. Schwamm, MD; Eric E. Smith, MD, MPH
Background-—The prognostic value of shock index (SI), heart rate divided by systolic blood pressure, in stroke for clinical
outcomes other than mortality is not well understood.
Methods and Results-—We examined the Get With The Guidelines–Stroke (GWTG-Stroke) data to explore the usefulness of SI in
predicting in-hospital outcomes in 425 808 acute stroke cases (mean age: 71.014.5 years; 48.8% male; 89.7% ischemic
stroke and 10.3% intracerebral hemorrhage) admitted between October 2012 and March 2015. Compared with patients with SI
of 0.5 to 0.7, patients with SI >0.7 (13.6% of the sample) had worse outcomes, with adjusted odds ratios of 2.00 (95%
conﬁdence interval [CI], 1.92–2.08) for in-hospital mortality, 1.46 (95% CI, 1.43–1.49) for longer length of hospital stay >4 days,
1.50 (95% CI, 1.47–1.54) for discharge destination other than home, 1.41 (95% CI, 1.38–1.45) for inability to ambulate
independently at discharge, and 1.52 (95% CI, 1.47–1.57) for modiﬁed Rankin Scale score of 3 to 6 at discharge. Results were
similar when analyses were conﬁned to those with available National Institutes of Health Stroke Scale (NIHSS) or within
individual stroke subtypes or when SI was additionally included in the models with or without blood pressure components. Every
0.1 increase in SI >0.5 was associated with signiﬁcantly worse outcomes in linear spline models. The addition of SI to existing
GWTG-Stroke mortality prediction models without NIHSS demonstrated modest improvement, but little to no improvement was
noted in models with NIHSS.
Conclusions-—SI calculated at the point of care may be a useful prognostic indicator to identify those with high risk of poor
outcomes in acute stroke, especially in hospitals with limited experience with NIHSS assessment. ( J Am Heart Assoc. 2018;7:
e007581. DOI: 10.1161/JAHA.117.007581.)
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T he shock index (SI), expressed as a ratio of heart rate tosystolic blood pressure (BP), was used initially to detect
hypovolemia in patients with septic or hypovolemic shock,
indicated by a SI value of >0.7.1,2 In addition, high SI has been
reported to have prognostic signiﬁcance in trauma3 and acute
cardiovascular events such as acute myocardial infarction and
stroke.4–6 Although heart rate and BP are important variables
in predicting acute stroke outcome, physiologically they are
linked to each other. Thus SI, which considers the ratio of
these variables, could perform better in predicting outcomes.
The SI may also reﬂect the development of Cushing reﬂex,
which is seen with ischemic brain injury caused by any stroke
subtypes. In addition to identifying patients at higher risk of
mortality, SI may also predict functional outcomes depicted
by discharge modiﬁed Rankin Scale and ambulatory status in
acute stroke.
McCall et al6 were the ﬁrst to report the relationship
between this simple and readily available physiological index
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and acute stroke mortality. In their UK-based multicenter
study (N=2121), the authors demonstrated that whereas the
higher SI is associated with increased risk of in-hospital
mortality, both low and high SIs (low SI indicating presence of
Cushing reﬂex) were associated with early mortality within 3
and 7 days, albeit with higher odds associated with high SI
compared with low SI. Although a clear plausible link exists
between high or low SI and stroke mortality outcome, no
study to date has examined the link between admission SI and
other important stroke outcomes such as length of hospital
stay and disability.
Using the Get With The Guidelines–Stroke (GWTG-Stroke)
data, we aimed to examine admission SI as a prognostic
marker not just for in-hospital mortality but also for other
important stroke outcomes (ie, in-hospital mortality, dis-
charge destination, discharge ambulatory status, length of
stay, and discharge modiﬁed Rankin score) controlling for
multiple potential confounders in a large cohort of stroke
patients. We were also interested in exploring whether adding
SI to existing mortality prediction scores would improve the
scores’ discriminative ability signiﬁcantly if SI were an
independent predictor of in-hospital mortality outcome.
Therefore, we also aimed to examine the added value of
inclusion of SI in existing GWTG-Stroke mortality prediction
models.
Methods
The American Heart Association (AHA) and American Stroke
Association GWTG-Stroke database data collection methods
have been described previously.7–10 In brief, participating
hospitals used the AHA’s Internet-based Patient Management
Tool (Quintiles) to enter data, receive decision support, and
obtain feedback via on demand reports of performance on
quality measures and recorded data from consecutive admis-
sions for acute ischemic stroke.
Trained hospital personnel abstracted data using the
Internet-based Patient Management Tool with standardized
data deﬁnitions and detailed coding instructions. The Internet-
based system performs checks to ensure that the reported data
are complete and internally consistent. In addition, data quality
is monitored for both completeness and accuracy. Hospitals
that participate must receive approval through their local
institutional review boards or a waiver of individual consent
under the common rule. Quintiles is the data collection
coordination center for the GWTG-Stroke program.11
The Duke Clinical Research Institute serves as the data
analysis center. Hospital characteristics (ie, academic teach-
ing status, bed size) were based on American Hospital
Association data.10 Past medical history was deﬁned on the
basis of preexisting conditions, with the exclusion of condi-
tions that were newly diagnosed during the hospital stay.
The predictor variable was SI, which is calculated as heart
rate divided by systolic BP. These variables were abstracted
by trained hospital personnel from the ﬁrst values recorded in
the emergency department record. For descriptive purposes,
3 categories of SI were deﬁned: SI <0.50, SI 0.50 to 0.70 as
the normal range, and SI >0.70. The outcomes of interest are
patient-relevant outcomes of in-hospital mortality; poor dis-
charge outcome, deﬁned as discharge other than home; poor
functional status at discharge, deﬁned as inability to ambulate
independently; disability at the time of discharged, deﬁned as
modiﬁed Rankin Scale (mRS) 3 to 6; and acute hospital length
of stay (LOS). For this study purpose, only intracerebral
hemorrhages were included as hemorrhagic stroke, and other
hemorrhages presenting with stroke symptoms such as
subarachnoid hemorrhages or subdural hematoma were
excluded.
Patient Inclusion and Exclusion
A total of 694 623 ischemic stroke patients were admitted
between October 2012 to April 1, 2015, at 1732 sites after
excluding hospitals with >25% missing medical history.
Further exclusions included patients with missing admission
heart rate or missing admission systolic BP (206 sites,
n=232 475); patients who transferred out, who left against
medical advice, or whose discharge disposition was missing,
not determined, or unable to be determined (8 sites,
n=13 618); and patients who were transferred in (4 sites,
n=66 658). Consequently, a total of 381 872 ischemic stroke
patients from 1514 sites were included in the current study
(Figure S1A). Similar inclusion and exclusion criteria were
Clinical Perspective
What Is New?
• Shock index (heart rate divided by systolic blood pressure)
at presentation to the emergency department predicts
patient-related clinical outcomes in ischemic and hemor-
rhagic stroke.
What Are the Clinical Implications?
• Shock index may be useful in providing prognostic infor-
mation to patients and relatives.
• Shock index may also serve as an easily available bedside
assessment tool to identify high-risk individuals and to guide
clinicians in providing appropriate management for these
patients.
• Shock index may be particularly useful in low-resource
settings or in hospitals with limited experience with stroke-
speciﬁc assessments such as the National Institutes of
Health Stroke Scale.
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applied for hemorrhagic stroke (intracerebral hemorrhage)
over the same study period (Figure S1B). Comparison of
patients who were included and excluded showed that a
majority of the characteristics are not signiﬁcantly different
between the 2 groups (data not shown).
Statistical Analysis
Patient characteristics are summarized and compared by SI
groups. To examine the association of SI and study outcomes,
adjusted multivariable logistic regression models with gener-
alized estimating equations to account for in-hospital cluster-
ing were created for each binary outcome. Multiple imputation
with 25-fold imputations were used to impute missing data for
covariates (see Table S1 for missing data) to account for
possible confounders. If a patient had missing medical history,
it was assumed that the medical condition did not occur.
National Institutes of Health Stroke Scale (NIHSS) score and
hospital characteristics were not imputed.
Regression models controlled for various important con-
founders that are known or likely to inﬂuence the relationship
between predictor and outcome. We adjusted demographic
characteristics such as age, sex, race, insurance, and
comorbidities (prosthetic heart valve, previous stroke, coro-
nary artery disease or prior myocardial infarction, diabetes
mellitus, peripheral vascular disease, hypertension, heart
failure). Other covariates included risk factors such as body
mass index (kg/m2), smoking status, and ambulatory status
before the current event, and whether the patient arrived at
the hospital during off-hours (regular hours deﬁned as 7 AM to
6 PM Monday–Friday). We also adjusted for other relevant
biochemical and physiological markers at the time of
admission: glucose (mg/dL), creatinine (mg/dL), diastolic
BP (mm Hg), international normalized ratio, total cholesterol,
HDL (high-density lipoprotein), LDL (low-density lipoprotein),
and triglycerides. Other clinical factors included presence or
absence of thrombotic complications of deep venous throm-
bosis and pulmonary embolism. We also controlled for the
following hospital characteristics: region, hospital type, num-
ber of beds, rural versus urban location, annual volume of
respective ischemic/hemorrhagic stroke admissions, annual
volume of tissue plasminogen activator administration (is-
chemic stroke patients only), and primary stroke center. For
those with NIHSS data (n=344 100), we also adjusted for
NIHSS, and analyses were conducted as subanalyses.
We repeated the analysis by including SI along with systolic
BP instead of diastolic BP. Given high collinearity, heart rate
was not included in the model. We also examined the
associations by including SI alone without BP components or
heart rate. We further assessed the association between both
systolic BP and heart rate on all outcomes using multivariable
logistic regression models.
To better understand the observed associations between
SI and outcomes examined within each SI category, we also
ﬁtted both linear and nonlinear models. The latter was done
by way of linear splines. First, restricted cubic spline models
were used (data not shown) as inference to help us to see the
shape of the curves and choose the knots (or cut points) for
linear splines.12 SI was modeled as cubic splines with knots at
5th, 50th and 95th percentiles of SI. Based on the results
from cubic spline, SI was modeled by using linear splines with
knots at 0.5 and 1.5.
Finally, we examined the usefulness of adding the SI to
existing GWTG-Stroke in-hospital mortality risk scores9,13 by
calculating C-index with or without SI in the original GWTG-
Stroke models with or without NIHSS (categorical as well as
every 0.1 increase in SI). Estimates of reclassiﬁcation were
also assessed using net reclassiﬁcation index analysis.
Calibration plots were also constructed using the continuous
SI models.
Results
The study cohort consisted of 425 808 patients with a
meanSD age of 71.0414.53 years (48.8% male), of whom
89.7% had ischemic stroke and 10.3% had intracerebral
hemorrhage. The meanSD ages were 70.414.6 and
69.514.8 years for patients ischemic and hemorrhagic
stroke, respectively. The majority of patients were white;
black patients represented 18% and 20% of the sample with
ischemic and hemorrhagic stroke subtypes, respectively
(versus 69% and 63% white, respectively).
Table 1 shows the total sample characteristics for selected
variables (overall and by SI categories). Statistically signiﬁcant
differences were noted among the 3 SI groups. Those with
higher SIs (>0.70) were more likely to be younger, and fewer
were male. They were more likely to arrive during off-hours
and tended to have more severe stroke, depicted by NIHSS
(median NIHSS values for SI of <0.5, 0.5–0.7, and >0.7 were
3, 4, and 6, respectively), and were less likely to be
independently ambulatory. Notable differences in cardiovas-
cular comorbidities included signiﬁcantly higher prevalence of
peripheral vascular disease and heart failure with signiﬁcantly
lower prevalence of hypertension compared with the other 2
categories. They had signiﬁcantly higher heart rate and lower
systolic BP on admission and were associated with signiﬁ-
cantly higher rates of poor outcomes for all outcomes
examined.
Tables S1 through S3 show the characteristics of all
variables included in the models and the outcomes of the
overall sample and the ischemic and hemorrhagic stroke
groups in detail. Figures S2A through S2C demonstrate the
sample’s SI distribution for the total sample and for the
ischemic and hemorrhagic stroke groups. With large numbers,
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Table 1. Characteristics and Outcomes for the Study Population and by SI Categories for Selected Variables
Variable
Overall
(N=425 808)
SI <0.50
(n=203 807)
SI 0.50–0.70
(n=163 980)
SI >0.70
(n=58 021) P Value
Characteristics
Age, y 71.0414.53 72.3913.57 70.0115.01 69.2115.88 <0.0001
Sex (male) 207 763 (48.79) 101 863 (49.98) 79 539 (48.51) 26 361 (45.43) <0.0001
Stroke type <0.0001
Ischemic 381 872 (89.68) 180 229 (88.43) 149 002 (90.87) 52 641 (90.73)
Hemorrhagic 43 936 (10.32) 23 578 (11.57) 14 978 (9.13) 5380 (9.27)
Race/ethnicity <0.0001
Other 13 629 (3.20) 6424 (3.15) 5321 (3.25) 1884 (3.25)
Asian 13 134 (3.09) 6705 (3.29) 4848 (2.96) 1581 (2.73)
Hispanic (any race) 30 802 (7.24) 14 502 (7.12) 12 187 (7.44) 4113 (7.09)
Black 79 285 (18.63) 38 601 (18.95) 30 139 (18.39) 10 545 (18.18)
White 288 753 (67.85) 137 491 (67.49) 111 397 (67.97) 39 865 (68.75)
Missing 205 (0.05) 84 (0.04) 88 (0.05) 33 (0.06)
Arrived during off-hours (yes)* 188 736 (44.32) 89 970 (44.14) 72 638 (44.30) 26 128 (45.03) 0.0007
Initial NIHSS (missing, 19.19%), median (IQR) 4 (1–10) 3 (1–9) 4 (1–10) 6 (2–14) <0.0001
Ambulatory status independent 127 089 (31.60) 63 606 (33.06) 49 701 (32.10) 13 782 (25.08) <0.0001
Medical history (yes)
Previous stroke/TIA 134 334 (31.56) 63 784 (31.30) 52 209 (31.85) 18 342 (31.62) 0.0019
CAD/prior MI 104 509 (24.55) 51 914 (25.48) 38 659 (23.58) 13 936 (24.03) <0.0001
Diabetes mellitus 144 248 (33.88) 69 071 (33.90) 55 983 (34.15) 19 194 (33.09) <0.0001
PVD 20 170 (4.74) 9479 (4.65) 7662 (4.67) 3029 (5.22) <0.0001
Hypertension 330 174 (77.56) 167 235 (82.07) 122 128 (74.50) 40 811 (70.36) <0.0001
Heart failure 39 167 (9.20) 16 217 (7.96) 15 526 (9.47) 7424 (12.80) <0.0001
Smoker (yes) 73 445 (17.25) 32 259 (15.83) 30 084 (18.35) 11 102 (19.14) <0.0001
BMI, kg/m2 28.076.78 28.166.56 28.146.89 27.507.18 <0.0001
Heart rate, beats/min 8218 7112 8614 10520 <0.0001
Systolic BP, mm Hg 16031 17727 14923 12623 <0.0001
Glucose, mg/dL 14572 14167 14675 15382 <0.0001
Cholesterol, mg/dL 17048 17348 16748 15848 <0.0001
Hospital characteristics
Primary stroke center (yes) 186 487 (43.80) 89 369 (43.85) 71 698 (43.72) 25 420 (43.81) 0.74
Region <0.0001
West 77 212 (18.15) 36 559 (17.95) 29 849 (18.22) 10 804 (18.64)
South 150 665 (35.41) 73 109 (35.90) 57 350 (35.00) 20 206 (34.86)
Midwest 77 841 (18.30) 37 440 (18.39) 29 773 (18.17) 10 628 (18.33)
Northeast 119 722 (28.14) 56 514 (27.75) 46 879 (28.61) 16 329 (28.17)
Missing 368 (0.09) 185 (0.09) 129 (0.08) 54 (0.09)
Outcomes
In-hospital mortality 27 903 (6.55) 11 895 (5.84) 9601 (5.85) 6407 (11.04) <0.0001
Died as inpatient
LOS >4 d (missing, n=12 884) 164 760 (39.90) 75 788 (37.96) 62 682 (39.42) 26 290 (48.43) <0.0001
Continued
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the overall P values for trends are signiﬁcant, although the
material differences between groups are relatively minor.
Those with higher SI in both stroke types were more likely to
be younger, female, prior anticoagulant users with higher
international normalized ratios, and current smokers and to
have higher prevalence of heart failure, lower cholesterol, and
higher glucose levels on admission. Not surprisingly, history of
hypertension and higher systolic BP and lower levels of heart
rate were less likely to be associated with higher SI. Higher
NIHSS was associated with higher SI in ischemic stroke, but
the trend appeared to be U shaped in hemorrhagic stroke;
high NIHSS was associated with both low and high SI.
Higher SI is also associated with poor outcomes of
mortality, ambulatory status at discharge, and disability
outcome (mRS >2) when crude comparisons were made. In-
hospital mortality for those with SI >0.7 was almost double
that of the other SI categories (11.0% versus 5.9%,
respectively). Also in this category, 55.7% patients were not
Table 1. Continued
Variable
Overall
(N=425 808)
SI <0.50
(n=203 807)
SI 0.50–0.70
(n=163 980)
SI >0.70
(n=58 021) P Value
Independent ambulatory status
No (missing, n=42 454) 188 221 (49.10) 88 897 (48.07) 71 606 (48.16) 27 718 (55.70) <0.0001
mRS >2 146 562 (61.34) 68 182 (60.03) 55 344 (60.05) 23 036 (69.42) <0.0001
Values presented are meanSD for continuous data and n (%) for categorical data, except as noted. BMI indicates body mass index; BP, blood pressure; CAD, coronary artery disease; IQR,
interquartile range; LOS, length of stay; MI, myocardial infarction; mRS, modiﬁed Rankin Scale; NIHSS, National Institute of Health Stroke Scale; PVD, peripheral vascular disease; SI, stroke
index; TIA, transient ischemic attack.
*Daytime regular hours were deﬁned as 7 AM to 6 PM Monday to Friday; all other times (including all day Saturday and Sunday) were considered off-hours.
Table 2. ORs and Corresponding 95% CIs for Those With Admission SI <0.5 and >0.7 Compared With SI 0.5–0.7 for Study
Outcomes for All Participants and by Ischemic and Hemorrhagic Stroke in GWTG-Stroke October 2012 to March 2015
Outcomes
SI <0.5 vs 0.5–0.7
OR (95% CI) P Value
SI >0.7 vs 0.5–0.7
OR (95% CI) P Value
In-hospital mortality
All 0.86 (0.83–0.89) <0.0001 2.00 (1.92–2.08) <0.0001
Ischemic stroke 0.79 (0.76–0.82) <0.0001 1.97 (1.87–2.06) <0.0001
Hemorrhagic stroke 1.01 (0.96–1.08) 0.64 1.85 (1.69–2.02) <0.0001
LOS (>4 vs 0–4 d)
All 0.87 (0.86–0.89) <0.0001 1.46 (1.43–1.49) <0.0001
Ischemic stroke 0.86 (0.84–0.87) <0.0001 1.53 (1.49–1.56) <0.0001
Hemorrhagic stroke 0.97 (0.92–1.02) 0.21 0.95 (0.89–1.02) 0.14
Discharge destination other than home
All 0.89 (0.87–0.90) <0.001 1.50 (1.47–1.54) <0.001
Ischemic stroke 0.88 (0.86–0.90) <0.001 1.49 (1.45–1.53) <0.001
Hemorrhagic stroke 0.97 (0.91–1.03) 0.32 1.53 (1.38–1.68) <0.001
Independent ambulatory status at discharge (no vs yes)
All 0.89 (0.87–0.91) <0.0001 1.41 (1.38–1.45) <0.0001
Ischemic stroke 0.89 (0.87–0.91) <0.0001 1.40 (1.36–1.44) <0.0001
Hemorrhagic stroke 0.89 (0.83–0.96) 0.0011 1.46 (1.32–1.62) <0.0001
Disability (mRS 3–6 vs 0–2)
All 0.88 (0.86–0.90) <0.0001 1.52 (1.47–1.57) <0.0001
Ischemic stroke 0.88 (0.86–0.90) <0.0001 1.49 (1.45–1.54) <0.0001
Hemorrhagic stroke 0.99 (0.90–1.08) 0.81 1.83 (1.59–2.09) <0.0001
Models adjusted for patient and hospital characteristics including systolic and diastolic blood pressure (see Methods for details). CI indicates conﬁdence interval; GWTG-Stroke, Get With
The Guidelines–Stroke; LOS, length of stay; mRS, modiﬁed Rankin Scale; OR, odds ratio; SI, stroke index.
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able to ambulate independently compared with 48% in other
2 categories. The crude rate of mRS >2 outcome also
increased 10% in those with SI >0.7 compared with the
other categories. LOS (>4 days) appears to be differently
associated with SI depending on stroke type; a higher
proportion of ischemic stroke patients with longer LOS had
higher SI (35.9% with SI <0.5, 38.1% with SI 0.5–0.7, and
48.3% with SI >0.7), whereas the reverse was true for
hemorrhagic stroke (53.9%, 52.2%, and 49.9%, respectively).
As expected, the individual components of SI, heart rate
and systolic BP, are also independent predictors of outcomes.
Both lower heart rate and higher systolic BP are also
independently associated with outcomes. Repeating the
analyses including SI or replacing diastolic BP with systolic
BP did not alter the results (data not shown).
Table 2 shows the odds ratios and corresponding 95%
conﬁdence intervals for the relationship between low (<0.5)
and high (>0.7) SI compared with normal SI (0.5–0.7) for each
selected outcome in the whole sample and separately for
ischemic and hemorrhagic stroke subtypes after controlling
for potential confounders listed in the study methods. The
results consistently showed the higher SI group (SI >0.7)
associated with worse outcomes including in-hospital mortal-
ity, longer LOS, likelihood of being discharged to a destination
other than home, inability to ambulate independently at the
time of hospital discharge, and association with higher
likelihood of disability deﬁned as mRS >2 (ie, discharge
mRS 3–6).
Table 3 shows the results for those with NIHSS data
available (n=344 100) with additional adjustment for NIHSS
score. Results were broadly similar to the whole sample
except for the nonsigniﬁcant association of the hemorrhagic
stroke subtype with longer LOS, although a point estimate
showed a similar direction (odds ratio: 1.07). Based on cubic
spline results, linear spline models were constructed for these
outcomes using knots at 0.5 and 0.7 to better understand the
dose-response relationship within each SI category. Odds
ratios and their corresponding 95% conﬁdence intervals were
calculated by incremental 0.1-U increase in SI, and results are
presented in Table 4. Consistent with earlier results, an
Table 3. ORs and Corresponding 95% CIs for Those With Admission SI <0.5 and >0.7 Compared With SI 0.5–0.7 for Study
Outcomes for All Participants (N=344 100) and by Ischemic Stroke (n=315 612) and Hemorrhagic Stroke (n=28 488) in GWTG-
Stroke October 2012 to March 2015 for Those With NIHSS Data
Models
SI <0.5
OR (95% CI) P Value
SI >0.7
OR (95% CI) P Value
In-hospital mortality
All 0.91 (0.88–0.94) <0.0001 1.53 (1.46–1.61) <0.0001
Ischemic stroke 0.89 (0.85–0.92) <0.0001 1.54 (1.46–1.62) <0.0001
Hemorrhagic stroke 0.98 (0.90–1.07) 0.70 1.39 (1.23–1.58) <0.0001
Length of stay (>4 vs 0–4 d)
All 0.90 (0.88–0.92) <0.0001 1.39 (1.36–1.43) <0.0001
Ischemic stroke 0.89 (0.88–0.91) <0.0001 1.42 (1.38–1.46) <0.0001
Hemorrhagic stroke 0.99 (0.93–1.05) 0.64 1.07 (0.98–1.17) 0.16
Discharge destination other than home
All 0.94 (0.92–0.95) <0.001 1.28 (1.24–1.31) <0.001
Ischemic stroke 0.93 (0.92–0.95) <0.001 1.28 (1.24–1.32) <0.001
Hemorrhagic stroke 0.95 (0.88–1.03) 0.18 1.23 (1.07–1.42) 0.004
Independent ambulatory status at discharge (no vs yes)
All 0.94 (0.92–0.97) <0.0001 1.25 (1.21–1.29) <0.0001
Ischemic stroke 0.95 (0.93–0.97) <0.0001 1.25 (1.21–1.28) <0.0001
Hemorrhagic stroke 0.89 (0.81–0.97) 0.0081 1.29 (1.12–1.49) <0.0001
Disability (mRS 3–6 vs 0–2)
All 0.94 (0.91–0.97) <0.0001 1.28 (1.23–1.33) <0.0001
Ischemic stroke 0.93 (0.91–0.96) <0.0001 1.27 (1.21–1.33) <0.0001
Hemorrhagic stroke 1.01 (0.91–1.13) 0.83 1.39 (1.15–1.69) 0.0007
Models were adjusted for patient and hospital characteristics, including systolic blood pressure, diastolic blood pressure, and NIHSS. See Methods for details. CI indicates conﬁdence
interval; GWTG-Stroke, Get With The Guidelines–Stroke; mRS, modiﬁed Rankin Scale; NIHSS, National Institute of Health Stroke Scale; OR, odds ratio; SI, stroke index.
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incremental increase of 0.1 U of SI in a linear fashion was
associated with worse outcomes for SI >0.5. With a lower
number of events, the results appeared to be less consistent
for hemorrhagic stroke. The cubic splines, which were
constructed for inference purposes of ﬁnding relevant knots
for linear spline models, are shown as Figures S4A–S4C to
S5A–S5C.
Table 5 shows the comparison of C-indexes calculated
with or without inclusion of SI for the original GWTG-Stroke
models with or without NIHSS for mortality outcome. There
were modest improvements in C-statistics by adding SI
(categorically or every 0.1-U incremental increase in SI) to the
original model without stroke severity,9 but little to no
improvement when SI was added to the model that also
included NIHSS.13 However, in the subsample with available
NIHSS data, exclusion of NIHSS from the model performed
less well. Table 5 also shows the results of the net
reclassiﬁcation index with values >0 for the model with SI,
conﬁrming the reclassiﬁcation improvement of the new model
(with SI) compared with the model without SI.
Figure shows the calibration plots for overall population
(Figure 1A), and then for ischemic stroke and intracerebral
hemorrhage cohorts separately (Figure 1B and 1C, respec-
tively) using the continuous SI models (ie, the last 3 models in
Table 5). This demonstrates the good ﬁt of model prediction
from the observed data.
Discussion
To our knowledge, this study is the ﬁrst to examine the
association between the SI and relevant clinical outcomes of
acute hospital LOS, discharge destination, ambulatory status
at the time of discharge, and disability outcome. We are the
ﬁrst to examine this association for speciﬁc stroke subtypes,
ischemic and hemorrhagic stroke, using the largest sample to
date, with >420 000 patients with unselected consecutively
admitted strokes to stroke services across the United States.
We found consistent predictive value of admission SI by
clear demonstration of signiﬁcantly worse outcomes with
higher levels of SI, including mortality. This association
Table 4. ORs and Corresponding 95% CIs for Every Incremental Increase in SI 0.1 Within Each SI Category (Coded as Linear Spline
With Knots at 0.5 and 0.7) for Study Outcomes for All Patients and by Ischemic and Hemorrhagic Stroke Patients Separately in
GWTG-Stroke (October 2012–March 2015)
Outcomes
SI 0.0–0.5
OR (95% CI)
SI 0.5–0.7
OR (95% CI)
SI >0.7
OR (95% CI)
In-hospital mortality
All 0.91 (0.89–0.94) 1.35 (1.26–1.45) 1.22 (1.10–1.35)
Ischemic stroke 1.00 (0.97–1.04) 1.37 (1.26–1.50) 1.20 (1.07–1.35)
Hemorrhagic stroke 0.83 (0.79–0.87) 1.22 (1.08–1.38) 1.26 (1.04–1.52)
LOS (>4 vs 0–4 d)
All 1.02 (1.00–1.03) 1.20 (1.16–1.25) 1.10 (1.04–1.17)
Ischemic stroke 1.01 (1.00–1.03) 1.22 (1.18–1.27) 1.13 (1.06–1.20)
Hemorrhagic stroke 1.07 (1.03–1.11) 1.00 (0.91–1.10) 0.96 (0.83–1.12)
Discharge destination other than home
All 1.01 (1.00–1.03) 1.18 (1.13–1.22) 1.16 (1.09–1.23)
Ischemic stroke 1.02 (1.01–1.04) 1.18 (1.13–1.23) 1.16 (1.09–1.23)
Hemorrhagic stroke 0.96 (0.91–1.01) 1.14 (1.00–1.30) 1.19 (0.97–1.46)
Independent ambulatory status at discharge (no vs yes)
All 1.02 (1.01–1.04) 1.17 (1.12–1.21) 1.12 (1.05–1.19)
Ischemic stroke 1.03 (1.01–1.04) 1.16 (1.12–1.21) 1.12 (1.05–1.19)
Hemorrhagic stroke 1.00 (0.95–1.06) 1.18 (1.02–1.35) 1.11 (0.89–1.39)
Disability (mRS 3–6 vs 0–2)
All 1.00 (0.98–1.02) 1.20 (1.14–1.26) 1.17 (1.08–1.26)
Ischemic stroke 1.01 (0.99–1.04) 1.19 (1.13–1.26) 1.16 (1.07–1.26)
Hemorrhagic stroke 0.94 (0.87–1.01) 1.15 (0.95–1.40) 1.29 (0.93–1.79)
Models were adjusted for baseline patient and hospital characteristics, including systolic and diastolic blood pressure. CI indicates conﬁdence interval; GWTG-Stroke, Get With The
Guidelines–Stroke; LOS, length of stay; mRS, modiﬁed Rankin Scale; OR, odds ratio; SI, stroke index.
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appears to be linear; every incremental increase in SI of 0.1
above an SI value of 0.5 appears to be an important
prognostic factor after taking into account individual prog-
nostic factors and clinical and hospital characteristics. McCall
and colleagues previously examined the link between SI and
acute stroke mortality in a much smaller sample (n=2121).
They found similar results demonstrating that high SI value
was associated with increased inpatient mortality (odds ratio:
1.85; 95% conﬁdence interval, 1.17–2.92).6 Of note, their
population was predominantly white (>95%), and they were
not able to control for some key variables of initial stroke
severity, such as NIHSS or poststroke complications. Our
results are broadly similar, with an overall estimated odds
ratio of 2.0 for mortality. We were able to examine the stroke
type–speciﬁc in-hospital mortality outcome, and the results
appeared to be consistent for both stroke subtypes.
Acute stroke causes an increase in sympathetic outﬂow to
the heart in an attempt to increase arterial BP and total
peripheral resistance to maintain cerebral blood ﬂow, accom-
panied by bradycardia known as Cushing reﬂex. Although
Cushing reﬂex is noticeable only with more severe ischemic
injury (direct effect of ischemic injury or secondary to
hemorrhagic stroke with resultant edema), the subtle phys-
iological changes may have already been occurring in any
ischemic stroke depending on the severity of ischemic injury.
Kalmer et al14 showed that the Cushing reﬂex indicated by
higher systolic BP and bradycardia predicted poor intracranial
perfusion and high intracranial pressure even with minimally
invasive procedures. Furthermore, mortality after a subarach-
noid hemorrhage was predicted by high intracranial pressure,
which demonstrated poor intracranial perfusion.15
A lower SI may also have prognostic signiﬁcance in stroke,
serving as an early marker of the Cushing reﬂex. Conversely,
large strokes with dysphagia or posterior circulation strokes
presenting with vomiting present a high risk of aspiration
pneumonia and may be associated with higher SI, as they are
more likely to cause higher heart rate and lower systolic BP.
Consequently, a potential U- or J-shaped relationship was
expected between SI and selected outcomes; however, we did
not ﬁnd the U-shaped relationship that was observed in the
study by McCall et al.6 Of note, McCall and colleagues did not
adjust for poststroke complications, which could inﬂuence the
outcomes examined.
The prognostic value of high SI has been previously
reported in conditions such as sepsis and severe volume
depletion.1,16 Previous studies have used SI to assess
outcomes in patients with community-acquired pneumonia
and acute circulatory failure and to predict those who would
require immediate intensive therapy.1,16–18 Moreover, a
recent study that used prospectively collected audit data
showed that an SI >1.0 was predictive of inpatient mortality in
individuals aged >90 years.19 It should be noted that SI can
vary during the process of care, as BP management in stroke
may inﬂuence its values, and thus it is expected that SI would
ﬂuctuate during the course of admission. This may have
attenuated the observed relationships.
Table 5. Mortality Outcome Prediction by Including SI in the Original GWTG-Stroke and GWTG-Stroke NIHSS Indexes in This
Cohort
Model
C-Index Comparison
Model With SI, NRI (95% CI)With SI Without SI
GWTG-Stroke without NIHSS*
In-hospital mortality (overall population) 0.816 0.809 0.250 (0.238–0.262)*
In-hospital mortality (ischemic stroke subgroup) 0.767 0.757 0.192 (0.163–0.222)*
In-hospital mortality (hemorrhagic stroke) 0.744 0.741 0.232 (0.218–0.246)*
Available NIHSS Data GWTG-Stroke With NIHSS Model†
In-hospital mortality (overall population) 0.875 0.873 0.802
In-hospital mortality (ischemic stroke subgroup) 0.855 0.852 0.767
In-hospital mortality (hemorrhagic stroke) 0.852 0.852 0.734
SI as 0.1 Increment
In-hospital mortality (overall population) 0.818 0.809 . . .
In-hospital mortality (ischemic stroke subgroup) 0.771 0.757 . . .
In-hospital mortality (hemorrhagic stroke) 0.748 0.741 . . .
CI indicates conﬁdence interval; GWTG-Stroke, Get With The Guidelines–Stroke; mRS, modiﬁed Rankin Scale; NIHSS, National Institute of Health Stroke Scale; NRI, net reclassiﬁcation
improvement; SI, shock index.
*NRI >0 means reclassiﬁcation improvement of the new model with SI compared with the model without SI.
†
NRI is for model with SI without NIHSS.
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Figure. Calibration plots for (A) the overall population, (B) the ischemic stroke cohort, and
(C) the intracerebral hemorrhage cohort.
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It was unknown whether incorporating SI into prognostic
scoring systems to improve existing scoring systems such as
GWTG-Stroke,9,13 iScore,20 SOAR (Stroke Subtype, Oxford
Community Stroke Project Classiﬁcation, Age, Prestroke
Modiﬁed Rankin) score,21 and mSOAR (modiﬁed SOAR)22
would improve the clinical prediction rules in stroke. We
extended our study aims to examine the usefulness of adding
SI to existing GWTG-Stroke scores.9,13 The addition of SI in the
absence of NIHSS data appeared to improve the prediction of
the GWTG-Stroke prognosis scoring system. Indeed, both heart
rate and systolic BP can be accurately measured and recorded
in any hospital setting without special training. Furthermore,
McCall et al already demonstrated that using SI has greater
predictive ability than systolic BP with regard to short-term
mortality.6 In clinical practice, information on vital signs can be
readily abstracted from routine examination; therefore, SI can
be easily calculated, and using SI could improve prediction of
outcomes for individual patients as well as risk adjustment.
Consequently, SI is particularly useful in jurisdictions where
standardized stroke scales that require training (eg, NIHSS) are
difﬁcult to implement in the emergency setting.
SI is a very simple index derived from 2 readily available
vital signs—heart rate and systolic BP—and its value at the
point of care can provide valuable prognostic information.
Indeed, Lee et al demonstrated in the GUSTO-I (Global
Utilization of Streptokinase and Tissue Plasminogen Activator
for Occluded Coronary Arteries-I) that both heart rate and BP
are among 5 predictors of 30-day mortality after acute
myocardial infarction.23 Contemporary ﬁndings in the ﬁeld of
cardiology showed similar results; in a cohort of 7187
patients with ST-segment elevation–myocardial infarction,
admission SI ≥0.7 was also associated with 1.6- and 1.5-fold
increased risk of 7- and 30-day major adverse cardiovascular
events, respectively.5
The key strengths of our work include the large sample size
and prospective data collection. We were able to conduct
robust statistical analysis with control for potential con-
founders including poststroke complications. We were able to
examine the outcomes by speciﬁc stroke subtypes and
robustly control for initial stroke severity in those with NIHSS
data available. Furthermore, our study has good ethnic mix
and thus is potentially applicable to other populations
including black, Asian, and Hispanic ethnic groups. The net
reclassiﬁcation index conﬁrms the reclassiﬁcation improve-
ment of SI, and calibration plots demonstrate the model’s
ﬁtness. This shows the usefulness of SI in a clinical setting
because SI is an easily obtainable physiological parameter.
Moreover, as a physiological index, the relationship between
SI and outcome is unlikely to be different between different
races or sexes; therefore, the results are generalizable.
Our study has some limitations. Hospital-based study
outcomes are conﬁned to in-hospital outcomes (ie, up to the
time of hospital discharge); however, the outcomes assessed
are important for stroke patients and their signiﬁcant others.
Moreover, prediction of LOS and discharge destination forms
an important aspect of service provision and assessment of
social care needs. We acknowledge large amounts of missing
data for some variables; however, we have used multiple
imputation to account for this. As an observational study,
causality between SI and poor stroke outcomes cannot be
drawn. Nevertheless, the observed associations have plausi-
ble explanations, observed prospectively and consistent with
the wider literature of cardiovascular outcome epidemiology.
Because data were from a hospital-based registry, some
stroke patients might not have been included, such as those
who died before admission. Patients and hospitals may not be
entirely representative of the US population, but the sample
population is comparable to all US patients hospitalized with
stroke.24
We were not able to assess the effect of unmeasured or
residual confounders; however, we were able to control for a
comprehensive list of potential confounding variables. A
substantial proportion of patients had missing NIHSS data;
however, that was because of nonrandom missingness, and
repeating the analyses in those who had NIHSS data showed
similar results. About of a third of patients were excluded for
various reasons including missing data, and this could
potentially limit generalizability; however, we were able to
impute for missing variables, and the percentage of missing
values is generally low or very low. As a physiological
parameter, the relationship between SI and outcome is
unlikely to be inﬂuenced by population characteristics;
therefore, the ﬁndings are generalizable and applicable to
any stroke patient in predicting likely outcome at the point of
care.
In summary, our study shows that SI is a signiﬁcant
predictor of important patient-related acute stroke outcomes
including mortality, acute hospital LOS, discharge destination,
ambulatory status at the time of discharge, and poststroke
disability. Our robust statistical analysis, taking into account
multiple confounding variables, showed a relationship
between SI and clinical outcomes; however, further studies
are required to demonstrate prognostic utility before it could
be widely adopted as a clinical tool. This information may be
useful in clinical practice for managing stroke patients, to
identify those with high risk of poor outcomes from the point
of contact, particularly if NIHSS is not available, and to better
inform patients and their signiﬁcant others about the
prognosis of these important outcomes.
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Table S1. Characteristics and outcomes by shock index (all) 
Variable Level Overall 
(N=425808) 
Shock Index <0.5 
(N=203807) 
Shock Index 0.50-
0.70 
(N=163980) 
Shock Index > 0.7 
(N=58021) 
P-value+ 
Demographics           
           
Age* Mean (SD)  71.0 (14.5)  72.4 (13.6)  70.0 (15.0)  69.2 (15.9)  
           
  N (%) N (%) N (%) N (%)  
Sex Female  218045 (51.21)  101944 (50.02)   84441 (51.49)   31660 (54.57) <0.0001 
Male  207763 (48.79)  101863 (49.98)   79539 (48.51)   26361 (45.43)  
           
Race Other (includes 
UTD) 
  13629  (3.20)    6424 (3.15)    5321 (3.25)    1884 (3.25) <0.0001 
Asian   13134  (3.09)    6705 (3.29)    4848 (2.96)    1581 (2.73)  
Hispanic (any 
race) 
  30802  (7.24)   14502 (7.12)   12187 (7.44)    4113 (7.09)  
Black   79285 (18.63)   38601 (18.95)   30139 (18.39)   10545 (18.18)  
White  288753 (67.85)  137491 (67.49)  111397 (67.97)   39865 (68.75)  
Missing     205 (0.05)      84 (0.04)      88 (0.05)      33 (0.06)  
           
Insurance Not 
Documented 
   1998  (0.49)     936 (0.48)     789 (0.51)     273 (0.49) <0.0001 
Self-Pay/No 
Insurance 
  25481  (6.28)   12140 (6.24)    9985 (6.39)    3356 (6.06)  
Medicare  153450 (37.80)   76054 (39.12)   57154 (36.59)   20242 (36.55)  
Medicaid   46954 (11.57)   19983 (10.28)   18948 (12.13)    8023 (14.49)  
Private/VA/ 
Champus/Other  
 178095 (43.87)   85305 (43.88)   69305 (44.37)   23485 (42.41)  
Missing   19830 (4.66)    9389 (4.61)    7799 (4.76)    2642  (4.55)  
           
Arrival and Admission 
Information 
          
           
Ambulatory status on 
Admission 
ND   75542 (18.78)   35887 (18.65)   28948 (18.70)   10707 (19.49) <0.0001 
Unable to 
ambulate 
 112865 (28.06)   49911 (25.94)   42941 (27.73)   20013 (36.42)  
With assistance 
(from person) 
  86662 (21.55)   42969 (22.34)   33251 (21.47)   10442 (19.00)  
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Variable Level Overall 
(N=425808) 
Shock Index <0.5 
(N=203807) 
Shock Index 0.50-
0.70 
(N=163980) 
Shock Index > 0.7 
(N=58021) 
P-value+ 
Able to 
ambulate 
independently 
(no help from 
another person) 
with or without 
device 
 127089 (31.60)   63606 (33.06)   49701 (32.10)   13782 (25.08)  
Missing   23650 (5.55)   11434 (5.61)    9139 (5.57)    3077 (5.30)  
           
Arrival Mode Unknown    4164 (1.01)    1958 (0.99)    1676 (1.06)     530 (0.98) <0.0001 
Private 
transport/taxi/ 
other from 
home/scene 
 159310 (38.76)   80496 (40.50)   61431 (38.83)   17383 (32.17)  
EMS from 
home/scene 
 247546 (60.23)  116307 (58.52)   95115 (60.11)   36124 (66.85)  
Missing   14788 (3.47)    5046 (2.48)    5758 (3.51)    3984 (6.87)  
           
Advanced notification by 
EMS? 
N/A    7016 (2.92)    3277 (2.91)    2597 (2.81)    1142 (3.25) <0.0001 
No   80002 (33.31)   37336 (33.12)   30766 (33.31)   11900 (33.91)  
Yes  153168 (63.77)   72116 (63.97)   59001 (63.88)   22051 (62.84)  
Missing  185622 (43.59)   91078 (44.69)   71616 (43.67)   22928 (39.52)  
           
Arrival during Off Hours 
(Regular hours:  
7 AM - 6 PM, M-F) 
Yes  188736 (44.32)   89970 (44.14)   72638 (44.30)   26128 (45.03) 0.0007 
No  237072 (55.68)  113837 (55.86)   91342 (55.70)   31893 (54.97)  
           
Medications Prior to 
Admission 
          
           
Antiplatelet or 
Anticoagulation 
medications 
Yes  228103 (53.63)  110758 (54.40)   86711 (52.94)   30634 (52.86) <0.0001 
No  197229 (46.37)   92836 (45.60)   77070 (47.06)   27323 (47.14)  
Missing     476 (0.11)     213 (0.10)     199 (0.12)      64 (0.11)  
           
Medical History           
           
Prosthetic heart valve Yes    5498 (1.29)    2370 (1.16)    2228 (1.36)     900 (1.55) <0.0001 
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Variable Level Overall 
(N=425808) 
Shock Index <0.5 
(N=203807) 
Shock Index 0.50-
0.70 
(N=163980) 
Shock Index > 0.7 
(N=58021) 
P-value+ 
No  420210 (98.71)  201396 (98.84)  161713 (98.64)   57101 (98.45)  
           
Previous stroke / TIA Yes  134334 (31.56)   63784 (31.30)   52209 (31.85)   18341 (31.62) 0.0019 
No  291374 (68.44)  139982 (68.70)  111732 (68.15)   39660 (68.38)  
           
CAD/ prior MI Yes  104509 (24.55)   51914 (25.48)   38659 (23.58)   13936 (24.03) <0.0001 
No  321199 (75.45)  151852 (74.52)  125282 (76.42)   44065 (75.97)  
           
Diabetes (combined) Yes  144248 (33.88)   69071 (33.90)   55983 (34.15)   19194 (33.09) <0.0001 
No  281460 (66.12)  134695 (66.10)  107958 (65.85)   38807 (66.91)  
           
PVD Yes   20170 (4.74)    9479 (4.65)    7662 (4.67)    3029 (5.22) <0.0001 
No  405538 (95.26)  194287 (95.35)  156279 (95.33)   54972 (94.78)  
           
Hypertension Yes  330174 (77.56)  167235 (82.07)  122128 (74.50)   40811 (70.36) <0.0001 
No   95534 (22.44)   36531 (17.93)   41813 (25.50)   17190 (29.64)  
           
Smoker Yes   73445 (17.25)   32259 (15.83)   30084 (18.35)   11102 (19.14) <0.0001 
No  352263 (82.75)  171507 (84.17)  133857 (81.65)   46899 (80.86)  
           
Heart failure Yes   39167 (9.20)   16217 (7.96)   15526 (9.47)    7424 (12.80) <0.0001 
No  386541 (90.80)  187549 (92.04)  148415 (90.53)   50577 (87.20)  
           
Medical History Panel 
missing 
Yes     100 (0.02)      41 (0.02)      39 (0.02)      20 (0.03) 0.14 
No  425708 (99.98)  203766 (99.98)  163941 (99.98)   58001 (99.97)  
           
Labs/Vitals at Admission           
           
Glucose (mg/dL)* Median 
(IQR) 
400601 121 
(102, 159) 
191827 119 
(101, 155) 
154374 121 
(102, 161) 
54400 126 
(105, 169) 
<0.0001 
Missing (%)  5.92  5.88  5.86  6.24  
           
INR* Median  
(IQR)  
361907 1.0 
(1.0, 1.1) 
173125 1.00 
(1.0, 1.1) 
139194 1.00 
(1.0, 1.1) 
49588 1.10 
(1.0, 1.2) 
<0.0001 
Missing (%)  15.01  15.05  15.12  14.53  
           
Total Cholesterol  Median 349921 165 170085 168 135408 164 44428 153 <0.0001 
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Variable Level Overall 
(N=425808) 
Shock Index <0.5 
(N=203807) 
Shock Index 0.50-
0.70 
(N=163980) 
Shock Index > 0.7 
(N=58021) 
P-value+ 
(mg/dL)* (IQR) (136, 197) (140, 201) (135, 196) (125, 185) 
Missing (%)  17.82  16.55  17.42  23.43  
           
HDL (mg/dL)* Median 346385 43.0 168392 43.0 134006 42.0 43987 40.0 <0.0001 
(IQR)   (34.0, 53.0)  (35.0, 54.0)  (34.0, 53.0)  (32.0, 51.0)  
Missing (%)  18.65  17.38  18.28  24.19  
LDL (mg/d)* Median 356058 94.0 173700 97.0 137543 94.0 44815 86.0 <0.0001 
(IQR)  (71.0,122.0)  (73.0,125.0)  (70.0,121.0)  (65.0,113.0)  
Missing (%)  16.38  14.77  16.12  22.76  
           
Triglycerides (mg/dL)* Median 348247 110.0 169262 112.0 134735 110.0 44250 105.0 <0.0001 
(IQR)  (78.0,160.0)  (79.0,162.0)  (78.0,160.0)  (76.0,150.0)  
Missing (%)  18.22  16.95  17.83  23.73  
Creatinine (mg/dL)* 
 
 
Systolic blood pressure 
(mmHg)* 
Median 411819 1.00 197298 1.00 158564 1.00 55957 1.00 <0.0001 
(IQR)  (0.80,1.30)  (0.80,1.30)  (0.80,1.30)  (0.80,1.40)  
Missing (%)  3.29  3.19  3.30  3.56  
Mean (SD)  159 (31)  177 (27)  149 (23)  126 (23) <0.0001 
          
           
Heart rate (bpm)* Mean (SD)  82 (18)  71 (12)  86 (14)  105 (20) <0.0001 
           
BMI (kg/m^2)* Mean (SD)  28.0 (6.8)  28.2 (6.6)  28.1 (6.9)  27.5 (7.2) <0.0001 
Missing (%)  11.11  10.90  11.21  11.61  
           
NIHSS score* Median (IQR) 344100 4 (1, 10) 167163 3 (1, 9) 132722 4 (1, 10) 44215 6 (2, 14) <0.0001 
Missing (%)  19.19  17.98  19.06  23.79  
           
           
  N (%) N (%) N (%) N (%)  
Hospital characteristics            
Region West   77212 (18.15)   36559 (17.95)   29849 (18.22)   10804 (18.64) <0.0001 
South  150665 (35.41)   73109 (35.90)   57350 (35.00)   20206 (34.86)  
Midwest   77841 (18.30)   37440 (18.39)   29773 (18.17)   10628 (18.33)  
Northeast  119722 (28.14)   56514 (27.75)   46879 (28.61)   16329 (28.17)  
Missing     368 (0.09)     185 (0.09)     129 (0.08)      54 (0.09)  
           
Teaching Hospital Yes  239688 (58.47)  112943 (57.67)   93151 (58.92)   33594 (60.01) <0.0001 
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Variable Level Overall 
(N=425808) 
Shock Index <0.5 
(N=203807) 
Shock Index 0.50-
0.70 
(N=163980) 
Shock Index > 0.7 
(N=58021) 
P-value+ 
No  170245 (41.53)   82913 (42.33)   64941 (41.08)   22391 (39.99)  
Missing   15875 (3.73)    7951 (3.90)    5888 (3.59)    2036 (3.51)  
           
Primary Stroke Center Yes  186487 (43.80)   89369 (43.85)   71698 (43.72)   25420 (43.81) 0.74 
No  239321 (56.20)  114438 (56.15)   92282 (56.28)   32601 (56.19)  
           
Outcomes           
           
In-hospital mortality Yes   27903 (6.55)   11895 (5.84)    9601 (5.85)    6407 (11.04) <0.0001 
No  397905 (93.45)  191912 (94.16)  154379 (94.15)   51614 (88.96)  
           
LOS greater than 4 days Yes  164760 (39.90)   75788 (37.96)   62682 (39.42)   26290 (48.43) <0.0001 
No  248164 (60.10)  123851 (62.04)   96323 (60.58)   27990 (51.57)  
Missing   12884 (3.03)    4168 (2.05)    4975 (3.03)    3741 (6.45)  
           
Independent ambulatory 
status 
Yes  195133 (50.90)   96017 (51.93)   77071 (51.84)   22045 (44.30) <0.0001 
No  188221 (49.10)   88897 (48.07)   71606 (48.16)   27718 (55.70)  
Missing   42454 (9.97)   18893 (9.27)   15303 (9.33)    8258 (14.23)  
           
mRS > 2  
(in documented patient 
cohort) 
Yes  146562 (61.34)   68182 (60.03)   55344 (60.05)   23036 (69.42) <0.0001 
No   92367 (38.66)   45399 (39.97)   36820 (39.95)   10148 (30.58)  
           
 
+ Note: P-values were calculated by comparing non-missing row values only; these percents sum to 100%.  The percent of missing row values is informative and 
therefore also presented here for convenience. 
+ P-values are based on Pearson chi-square tests for all categorical row variables. 
* P-values are based on chi-square rank based group means score statistics for all continuous/ordinal row variables (designated by *). 
* This is equivalent to Kruskal-Wallis tests. 
EMS: emergency medical service; INR: international normalized ratio; LOS: length of stay; NIHSS: National Institute of Health Stroke Scale; mRS: modified 
Rankin Scale; TIA: Transient Ischemic Attack; CAD: coronary artery disease; MI: myocardial infarction; PVD: peripheral vascular disease; HDL: high density 
lipoprotein; LDL: low density lipoprotein; BMI: body mass index; IV rt-PA: intravenous recombinant tissue plasminogen activator.  
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Table S2. Characteristics and outcomes by shock index (Acute Ischemic Stroke cohort). 
Variable Level Overall 
(N=381872) 
Shock Index <0.5 
(N=180229) 
Shock Index 0.50-
0.70 
(N=149002) 
Shock Index > 0.7 
(N=52641) 
P-value+ 
Demographics           
           
Age* Mean (SD)  71.2 (14.4)  72.6 (13.4)  70.1 (15.0)  69.5 (15.8) <0.0001 
           
  N (%) N (%) N (%) N (%)  
Sex Female  196653 (51.50)   90732 (50.34)   77035 (51.70)   28886 (54.87) <0.0001 
Male  185219 (48.50)   89497 (49.66)   71967 (48.30)   23755 (45.13)  
           
Race Other (includes 
UTD) 
  11898 (3.12)    5501 (3.05)    4735 (3.18)    1662 (3.16) <0.0001 
Asian   10831 (2.84)    5411 (3.00)    4090 (2.75)    1330 (2.53)  
Hispanic (any 
race) 
  26753 (7.01)   12324 (6.84)   10810 (7.26)    3619 (6.88)  
Black   70913 (18.58)   33872 (18.80)   27478 (18.45)    9563 (18.18)  
White  261293 (68.46)  123048 (68.30)  101809 (68.36)   36436 (69.26)  
Missing     184 (0.05)      73 (0.04)      80 (0.05)      31 (0.06)  
           
Insurance Not 
Documented 
   1681 (0.46)     773 (0.45)     682 (0.48)     226 (0.45) <0.0001 
Self Pay/No 
Insurance 
  22023 (6.05)   10146 (5.90)    8917 (6.28)    2960 (5.89)  
Medicare  138468 (38.03)   67881 (39.48)   52068 (36.69)   18519 (36.87)  
Medicaid   41567 (11.42)   17255 (10.04)   17072 (12.03)    7240 (14.41)  
Private/VA/Cha
mpus/Other 
Insurance 
 160338 (44.04)   75883 (44.13)   63171 (44.51)   21284 (42.37)  
Missing   17795 (4.66)    8291 (4.60)    7092 (4.76)    2412 (4.58)  
           
Arrival and Admission 
Information 
          
           
Ambulatory status on 
Admission 
ND   67479 (18.72)   31534 (18.55)   26202 (18.64)    9743 (19.57) <0.0001 
Unable to 
ambulate 
  91637 (25.43)   38574 (22.69)   35951 (25.57)   17112 (34.36)  
With assistance 
(from person) 
  81249 (22.54)   40039 (23.55)   31351 (22.30)    9859 (19.80)  
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Variable Level Overall 
(N=381872) 
Shock Index <0.5 
(N=180229) 
Shock Index 0.50-
0.70 
(N=149002) 
Shock Index > 0.7 
(N=52641) 
P-value+ 
Able to 
ambulate 
independently 
(no help from 
another person) 
w/ or w/o device 
 120033 (33.31)   59874 (35.22)   47078 (33.49)   13081 (26.27)  
Missing   21474 (5.62)   10208 (5.66)    8420 (5.65)    2846 (5.41)  
           
Arrival Mode ND or Unknown    3789 (1.03)    1790 (1.02)    1530 (1.06)     469 (0.96) <0.0001 
Private 
transport/taxi/ot
her from 
home/scene 
 149094 (40.49)   75124 (42.79)   57700 (40.16)   16270 (33.24)  
EMS from 
home/scene 
 215322 (58.48)   98666 (56.19)   84449 (58.78)   32207 (65.80)  
Missing   13667 (3.58)    4649 (2.58)    5323 (3.57)    3695 (7.02)  
           
Advanced notification by 
EMS? 
N/A    6137 (2.94)    2829 (2.96)    2294 (2.80)    1014 (3.24) 0.0007 
No/ND   69936 (33.48)   31943 (33.40)   27416 (33.43)   10577 (33.81)  
Yes  132841 (63.59)   60854 (63.64)   52298 (63.77)   19689 (62.94)  
Missing  172958 (45.29)   84603 (46.94)   66994 (44.96)   21361 (40.58)  
           
Arrival during Off Hours 
(Regular hours: 7 AM - 6 
PM, M-F) 
Yes  167200 (43.78)   78373 (43.49)   65336 (43.85)   23491 (44.62) <0.0001 
No  214672 (56.22)  101856 (56.51)   83666 (56.15)   29150 (55.38)  
           
Medications Prior to 
Admission 
          
           
Antiplatelet or 
Anticoagulation 
medications 
Yes  207973 (54.52)   99754 (55.40)   79948 (53.72)   28271 (53.76) <0.0001 
No  173490 (45.48)   80298 (44.60)   68879 (46.28)   24313 (46.24)  
Missing     409 (0.11)     177 (0.10)     175 (0.12)      57 (0.11)  
           
Antiplatelet Yes  181509 (50.90)   89168 (52.42)   69188 (49.88)   23153 (48.46) <0.0001 
No  175100 (49.10)   80945 (47.58)   69526 (50.12)   24629 (51.54)  
Missing   25263 (6.62)   10116 (5.61)   10288 (6.90)    4859 (9.23)  
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Variable Level Overall 
(N=381872) 
Shock Index <0.5 
(N=180229) 
Shock Index 0.50-
0.70 
(N=149002) 
Shock Index > 0.7 
(N=52641) 
P-value+ 
Anticoagulation Yes   40470 (18.06)   16340 (16.08)   16418 (18.41)    7712 (23.14) <0.0001 
No  183650 (81.94)   85280 (83.92)   72749 (81.59)   25621 (76.86)  
Missing  157752 (41.31)   78609 (43.62)   59835 (40.16)   19308 (36.68)  
           
Medical History           
           
Prosthetic heart valve Yes    4876 (1.28)    2057 (1.14)    2013 (1.35)     806 (1.53) <0.0001 
No  376909 (98.72)  178137 (98.86)  146955 (98.65)   51817 (98.47)  
           
Previous stroke / TIA Yes  122605 (32.11)   57691 (32.02)   48090 (32.28)   16824 (31.97) 0.2 
No  259180 (67.89)  122503 (67.98)  100878 (67.72)   35799 (68.03)  
           
CAD/ prior MI Yes   96240 (25.21)   47269 (26.23)   35965 (24.14)   13006 (24.72) <0.0001 
No  285545 (74.79)  132925 (73.77)  113003 (75.86)   39617 (75.28)  
           
Diabetes (combined) Yes  132595 (34.73)   62749 (34.82)   52028 (34.93)   17818 (33.86) <0.0001 
No  249190 (65.27)  117445 (65.18)   96940 (65.07)   34805 (66.14)  
           
PVD Yes   18630 (4.88)    8666 (4.81)    7146 (4.80)    2818 (5.36) <0.0001 
No  363155 (95.12)  171528 (95.19)  141822 (95.20)   49805 (94.64)  
           
Hypertension Yes  297119 (77.82)  148336 (82.32)  111465 (74.82)   37318 (70.92) <0.0001 
No   84666 (22.18)   31858 (17.68)   37503 (25.18)   15305 (29.08)  
           
Smoker Yes   67996 (17.81)   29441 (16.34)   28180 (18.92)   10375 (19.72) <0.0001 
No  313789 (82.19)  150753 (83.66)  120788 (81.08)   42248 (80.28)  
           
Heart failure Yes   36131 (9.46)   14710 (8.16)   14479 (9.72)    6942 (13.19) <0.0001 
No  345654 (90.54)  165484 (91.84)  134489 (90.28)   45681 (86.81)  
           
Medical History Panel 
missing 
Yes      87 (0.02)      35 (0.02)      34 (0.02)      18 (0.03) 0.142 
No  381785 (99.98)  180194 (99.98)  148968 (99.98)   52623 (99.97)  
           
Labs/Vitals at Admission           
           
Glucose (mg/dL)* Median  
(IQR)  
 359869 120 
(101, 158) 
169952 117 
(100, 153) 
140472 120 
(102, 160) 
49445 125 
(104, 167) 
<0.0001 
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Variable Level Overall 
(N=381872) 
Shock Index <0.5 
(N=180229) 
Shock Index 0.50-
0.70 
(N=149002) 
Shock Index > 0.7 
(N=52641) 
P-value+ 
Missing (%)  5.76  5.70  5.72  6.07  
           
INR* 
 
Median 
(IQR) 
 322082 1.0 
(1.0, 1.1) 
151612 1.0 
(1.0, 1.1) 
125670 1.0 
(1.0, 1.1) 
44800 1.1 
(1.0, 1.2) 
<0.0001 
Missing (%)  15.66  15.88  15.66  14.90  
           
Total Cholesterol (mg/dL)* Median 
(IQR) 
 329507 165 
(136, 197) 
158541 168 
(140, 201) 
128509 164 
(135, 196) 
42457 152 
(125, 185) 
<0.0001 
Missing (%)  13.71  12.03  13.75  19.35  
           
HDL (mg/dL)* Median 
(IQR) 
 326356 42.0 
(34.0, 53.0) 
157073 43.0 
(35.0, 53.0) 
127235 42.0 
(34.0, 52.0) 
42048 40.0 
(32.0, 51.0) 
<0.0001 
Missing (%)  14.54  12.85  14.61  20.12  
LDL (mg/dL)* Median 
(IQR)  
 335305 95.0 
(71.0,123.0) 
161935 97.0 
(73.0,126.0) 
130545 94.0 
(70.0,121.0) 
42825 86.0 
(65.0,113.0) 
<0.0001 
Missing (%)  12.19  10.15  12.39  18.65  
           
Triglycerides (mg/dL)* Median 
(IQR) 
 327831 111.0 
(79.0,161.0) 
157716 113.0 
(80.0,164.0) 
127838 111.0 
(79.0,161.0) 
42277 105.0 
(77.0,151.0) 
<0.0001 
Missing (%)  14.15  12.49  14.20  19.69  
           
Creatinine (mg/dL)* Median 
(IQR) 
 369488 1.0 
(0.8, 1.3) 
174569 1.0 
(0.8, 1.3) 
144125 1.0 
(0.8, 1.3) 
50794 1.0 
(0.8, 1.4) 
<0.0001 
Missing (%)  3.24  3.14  3.27  3.51  
           
Systolic blood pressure 
(mmHg)* 
Mean (SD)  158 (31)  175 (27)  148 (23)  125 (22) <0.0001 
           
Heart rate (bpm)* Mean (SD)  82 (18)  71 (12)  86 (13)  105 (20) <0.0001 
           
BMI (kg/m^2)* Mean (SD)  28.1 (6.8)  28.2 (6.5)  28.2 (6.9)  27.6 (7.2) <0.0001 
Missing (%)  10.92  10.69  11.06  11.34  
           
NIHSS score* Median (IQR)  315612 4 (1, 9) 151092 3(1, 8) 123151 4 (1, 9) 41369 5 (2, 13) <0.0001 
Missing (%)  17.35  16.17  17.35  21.41  
           
  N (%) N (%) N (%) N (%)  
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Variable Level Overall 
(N=381872) 
Shock Index <0.5 
(N=180229) 
Shock Index 0.50-
0.70 
(N=149002) 
Shock Index > 0.7 
(N=52641) 
P-value+ 
Hospital characteristics           
           
Region West   68216 (17.88)   31747 (17.63)   26769 (17.98)    9700 (18.44) <0.0001 
South  135832 (35.60)   65024 (36.11)   52387 (35.18)   18421 (35.02)  
Midwest   70033 (18.35)   33216 (18.45)   27137 (18.23)    9680 (18.40)  
Northeast  107481 (28.17)   50081 (27.81)   42602 (28.61)   14798 (28.13)  
Missing     310 (0.08)     161 (0.09)     107 (0.07)      42 (0.08)  
           
Teaching Hospital Yes  211514 (57.61)   97990 (56.67)   83497 (58.19)   30027 (59.14) <0.0001 
No  155660 (42.39)   74917 (43.33)   60000 (41.81)   20743 (40.86)  
Missing   14698 (3.85)    7322 (4.06)    5505 (3.69)    1871 (3.55)  
           
Primary Stroke Center Yes  165606 (43.37)   78075 (43.32)   64579 (43.34)   22952 (43.60) 0.50 
No  216266 (56.63)  102154 (56.68)   84423 (56.66)   29689 (56.40)  
           
Outcomes           
           
In-hospital mortality Yes   16859 (4.41)    5980 (3.32)    6243 (4.19)    4636 (8.81) <0.0001 
No  365013 (95.59)  174249 (96.68)  142759 (95.81)   48005 (91.19)  
           
LOS greater than 4 days Yes  142028 (38.40)   63252 (35.87)   55035 (38.12)   23741 (48.29) <0.0001 
No  227862 (61.60)  113106 (64.13)   89329 (61.88)   25427 (51.71)  
Missing   11982 (3.14)    3871 (2.15)    4638 (3.11)    3473 (6.60)  
           
Independent ambulatory 
status 
Yes  184672 (52.49)   90512 (53.88)   73185 (53.21)   20975 (45.30) <0.0001 
No  167155 (47.51)   77473 (46.12)   64354 (46.79)   25328 (54.70)  
Missing   30045 (7.87)   12244 (6.79)   11463 (7.69)    6338 (12.04)  
           
mRS > 2 (in documented 
patient cohort) 
Yes  124114 (58.59)   56032 (56.58)   47965 (57.79)   20117 (67.46) <0.0001 
No   87727 (41.41)   42997 (43.42)   35028 (42.21)    9702 (32.54)  
           
+ Note: P-values were calculated by comparing non-missing row values only; these percents sum to 100%.  The percent of missing row values is informative and 
therefore also presented here for convenience. 
+ P-values are based on Pearson chi-square tests for all categorical row variables. 
* P-values are based on chi-square rank based group means score statistics for all continuous/ordinal row variables (designated by *). 
* This is equivalent to Kruskal-Wallis tests. 
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EMS: emergency medical service; INR: international normalized ratio; LOS: length of stay; NIHSS: National Institute of Health Stroke Scale; mRS: modified 
Rankin Scale; TIA: Transient Ischemic Attack; CAD: coronary artery disease; MI: myocardial infarction; PVD: peripheral vascular disease; HDL: high density 
lipoprotein; LDL: low density lipoprotein; BMI: body mass index; IV rt-PA: intravenous recombinant tissue plasminogen activator.  
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Table S3. Characteristics and outcomes by shock index (Intracerebral Hemorrhage cohort). 
Variable Level Overall 
(N=43936) 
Shock Index <0.5 
(N=23578) 
Shock Index 0.50-
0.70 
(N=14978) 
Shock Index > 0.7 
(N=5380) 
P-value+ 
Demographics           
           
Age* Mean (SD)  69.7 (15.3)  70.6 (14.7)  69.4 (15.4)  66.6 (16.8) <0.0001 
           
  N (%) N (%) N (%) N (%)  
Sex Female   21392 (48.69)   11212 (47.55)    7406 (49.45)    2774 (51.56) <0.0001 
Male   22544 (51.31)   12366 (52.45)    7572 (50.55)    2606 (48.44)  
           
Race Other (includes 
UTD) 
   1731 (3.94)     923 (3.92)     586 (3.91)     222 (4.13) <0.0001 
Asian    2303 (5.24)    1294 (5.49)     758 (5.06)     251 (4.67)  
Hispanic (any 
race) 
   4049 (9.22)    2178 (9.24)    1377 (9.20)     494 (9.19)  
Black    8372 (19.06)    4729 (20.07)    2661 (17.78)     982 (18.26)  
White   27460 (62.53)   14443 (61.28)    9588 (64.05)    3429 (63.76)  
Missing      21 (0.05)      11 (0.05)       8 (0.05)       2 (0.04)  
           
Insurance Not 
Documented 
    317 (0.76)     163 (0.73)     107 (0.75)      47 (0.91) <0.0001 
Self Pay/No 
Insurance 
   3458 (8.25)    1994 (8.87)    1068 (7.48)     396 (7.69)  
Medicare   14982 (35.76)    8173 (36.36)    5086 (35.64)    1723 (33.46)  
Medicaid    5387 (12.86)    2728 (12.14)    1876 (13.15)     783 (15.20)  
Private/VA/Cha
mpus/Other 
Insurance 
  17757 (42.38)    9422 (41.91)    6134 (42.98)    2201 (42.74)  
Missing    2035 (4.63)    1098 (4.66)     707 (4.72)     230 (4.28)  
           
Arrival and Admission 
Information 
          
           
Ambulatory status on 
Admissio 
ND    8063 (19.31)    4353 (19.47)    2746 (19.26)     964 (18.72) <0.0001 
Unable to 
ambulate 
  21228 (50.83)   11337 (50.72)    6990 (49.02)    2901 (56.34)  
With assistance 
(from person) 
   5413 (12.96)    2930 (13.11)    1900 (13.32)     583 (11.32)  
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Variable Level Overall 
(N=43936) 
Shock Index <0.5 
(N=23578) 
Shock Index 0.50-
0.70 
(N=14978) 
Shock Index > 0.7 
(N=5380) 
P-value+ 
Able to 
ambulate 
independently 
(no help from 
another person) 
w/ or w/o device 
   7056 (16.90)    3732 (16.70)    2623 (18.40)     701 (13.61)  
Missing    2176 (4.95)    1226 (5.20)     719 (4.80)     231 (4.29)  
           
Arrival Mode ND or Unknown     375 (0.88)     168 (0.72)     146 (1.00)      61 (1.20) <0.0001 
Private 
transport/taxi/ot
her from 
home/scene 
  10216 (23.86)    5372 (23.17)    3731 (25.65)    1113 (21.86)  
EMS from 
home/scene 
  32224 (75.26)   17641 (76.10)   10666 (73.34)    3917 (76.94)  
Missing    1121 (2.55)     397 (1.68)     435 (2.90)     289 (5.37)  
           
Advanced notification by 
EMS? 
N/A     879 (2.81)     448 (2.62)     303 (2.93)     128 (3.36) <0.0001 
No/ND   10066 (32.19)    5393 (31.53)    3350 (32.35)    1323 (34.70)  
Yes   20327 (65.00)   11262 (65.85)    6703 (64.73)    2362 (61.95)  
Missing   12664 (28.82)    6475 (27.46)    4622 (30.86)    1567 (29.13)  
           
Arrival during Off Hours 
(Regular hours: 7 AM - 6 
PM, M-F) 
Yes   21536 (49.02)   11597 (49.19)    7302 (48.75)    2637 (49.01) 0.71 
No   22400 (50.98)   11981 (50.81)    7676 (51.25)    2743 (50.99)  
           
Medications Prior to 
Admission 
          
           
Antiplatelet or 
Anticoagulation 
medications 
Yes   20130 (45.89)   11004 (46.74)    6763 (45.23)    2363 (43.98) 0.0002 
No   23739 (54.11)   12538 (53.26)    8191 (54.77)    3010 (56.02)  
Missing      67 (0.15)      36 (0.15)      24 (0.16)       7 (0.13)  
           
Antiplatelet Yes   15411 (39.03)    8685 (40.60)    5088 (37.97)    1638 (34.89) <0.0001 
No   24075 (60.97)   12705 (59.40)    8313 (62.03)    3057 (65.11)  
Missing    4450 (10.13)    2188 (9.28)    1577 (10.53)     685 (12.73)  
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Variable Level Overall 
(N=43936) 
Shock Index <0.5 
(N=23578) 
Shock Index 0.50-
0.70 
(N=14978) 
Shock Index > 0.7 
(N=5380) 
P-value+ 
Anticoagulation Yes    7325 (22.93)    3615 (21.71)    2599 (23.44)    1111 (26.46) <0.0001 
No   24614 (77.07)   13036 (78.29)    8491 (76.56)    3087 (73.54)  
Missing   11997 (27.31)    6927 (29.38)    3888 (25.96)    1182 (21.97)  
           
Medical History           
           
Prosthetic heart valve Yes     622 (1.42)     313 (1.33)     215 (1.44)      94 (1.75) 0.06 
No   43301 (98.58)   23259 (98.67)   14758 (98.56)    5284 (98.25)  
           
Previous stroke / TIA Yes   11729 (26.70)    6093 (25.85)    4119 (27.51)    1517 (28.21) <0.0001 
No   32194 (73.30)   17479 (74.15)   10854 (72.49)    3861 (71.79)  
           
CAD/ prior MI Yes    8269 (18.83)    4645 (19.71)    2694 (17.99)     930 (17.29) <0.0001 
No   35654 (81.17)   18927 (80.29)   12279 (82.01)    4448 (82.71)  
           
Diabetes (combined) Yes   11653 (26.53)    6322 (26.82)    3955 (26.41)    1376 (25.59) 0.17 
No   32270 (73.47)   17250 (73.18)   11018 (73.59)    4002 (74.41)  
           
PVD Yes    1540 (3.51)     813 (3.45)     516 (3.45)     211 (3.92) 0.21 
No   42383 (96.49)   22759 (96.55)   14457 (96.55)    5167 (96.08)  
           
Hypertension Yes   33055 (75.26)   18899 (80.18)   10663 (71.21)    3493 (64.95) <0.0001 
No   10868 (24.74)    4673 (19.82)    4310 (28.79)    1885 (35.05)  
           
Smoker Yes    5449 (12.41)    2818 (11.95)    1904 (12.72)     727 (13.52) 0.0027 
No   38474 (87.59)   20754 (88.05)   13069 (87.28)    4651 (86.48)  
           
Heart failure Yes    3036 (6.91)    1507 (6.39)    1047 (6.99)     482 (8.96) <0.0001 
No   40887 (93.09)   22065 (93.61)   13926 (93.01)    4896 (91.04)  
           
Medical History Panel 
missing 
Yes      13 (0.03)       6 (0.03)       5 (0.03)       2 (0.04) 0.85 
No   43923 (99.97)   23572 (99.97)   14973 (99.97)    5378 (99.96)  
           
Labs/Vitals at Admission           
           
Glucose (mg/dL)* Median 
(IQR) 
  40732 131 
(108, 169) 
21875 130 
(107, 167) 
13902 130 
(107, 168) 
4955 139 
(111, 184) 
<0.0001 
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Variable Level Overall 
(N=43936) 
Shock Index <0.5 
(N=23578) 
Shock Index 0.50-
0.70 
(N=14978) 
Shock Index > 0.7 
(N=5380) 
P-value+ 
Missing (%)  7.29  7.22  7.18  7.90  
           
INR* Median 
(IQR) 
  39825 1.0 
(1.0, 1.2) 
21513 1.0 
(1.0, 1.1) 
13524 1.0 
(1.0, 1.2) 
4788 1.1 
(1.0, 1.4) 
<0.0001 
Missing (%)  9.36  8.76  9.71  11.00  
           
Total Cholesterol (mg/dL)* Median 
(IQR)  
  20414 165 
(138, 195) 
11544 168 
(141, 198) 
6899 163 
(136, 193) 
1971 156 
(125, 186) 
<0.0001 
Max  671.00  671.00  401.00  382.00  
Missing (%)  53.54  51.04  53.94  63.36  
           
HDL (mg/dL)* Median 
(IQR) 
  20029 47.0 
(37.0, 58.0) 
11319 47.0 
(38.0, 59.0) 
6771 47.0 
(37.0, 58.0) 
1939 44.0 
(34.0, 56.0) 
<0.0001 
Missing (%)  54.41  51.99  54.79  63.96  
           
LDL (mg/dL)* Median 
(IQR) 
  20753 93.0 
(71.0,119.0) 
11765 95.0 
(73.0,121.0) 
6998 91.0 
(70.0,117.0) 
1990 88.0 
(65.0,113.0) 
<0.0001 
Missing (%)  52.77  50.10  53.28  63.01  
           
Triglycerides (mg/dL)* Median 
(IQR) 
  20416 95.0 
(69.0,136.0) 
11546 96.0 
(69.0,137.0) 
6897 94.0 
(69.0,135.0) 
1973 97.0 
(70.0,137.0) 
0.22 
Missing (%)  53.53  51.03  53.95  63.33  
           
Creatinine (mg/dL)* Median 
(IQR) 
  42331 1.0 
(0.8, 1.2) 
22729 1.0 
(0.8, 1.2) 
14439 0.9 
(0.7, 1.2) 
5163 1.0 
(0.8, 1.3) 
<0.0001 
Missing (%)  3.65  3.60  3.60  4.03  
           
Systolic blood pressure 
(mmHg)* 
Mean (SD)  169 (35)  187 (30)  155 (27)  128 927) <0.0001 
           
 Mean (SD)  83 (19)  73 (13)  90 (16)  109 (21)       <0.0001 
           
BMI (kg/m^2)* Mean  27.5 (6.9)  27.7 (6.8)  27.5 (7.0)  26.9 (7.0)       <0.0001 
Missing (%)  12.75  12.46  12.67  14.31  
           
NIHSS score* Median (IQR)   28488 9 (3, 20) 16071 10 (3, 20) 9571 8 (2, 19) 2846 11 (3, 23) <0.0001 
Missing (%)  35.16  31.84  36.10  47.10  
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Variable Level Overall 
(N=43936) 
Shock Index <0.5 
(N=23578) 
Shock Index 0.50-
0.70 
(N=14978) 
Shock Index > 0.7 
(N=5380) 
P-value+ 
           
  N (%) N (%) N (%) N (%)  
Hospital characteristics           
           
Region West    8996 (20.50)    4812 (20.43)    3080 (20.59)    1104 (20.57) 0.09 
South   14833 (33.81)    8085 (34.33)    4963 (33.18)    1785 (33.25)  
Midwest    7808 (17.79)    4224 (17.93)    2636 (17.63)     948 (17.66)  
Northeast   12241 (27.90)    6433 (27.31)    4277 (28.60)    1531 (28.52)  
Missing      58 (0.13)      24 (0.10)      22 (0.15)      12 (0.22)  
           
Teaching Hospital Yes   28174 (65.89)   14953 (65.16)    9654 (66.15)    3567 (68.40) <0.0001 
No   14585 (34.11)    7996 (34.84)    4941 (33.85)    1648 (31.60)  
Missing    1177 (2.68)     629 (2.67)     383 (2.56)     165 (3.07)  
           
Primary Stroke Center Yes   20881 (47.53)   11294 (47.90)    7119 (47.53)    2468 (45.87) 0.03 
No   23055 (52.47)   12284 (52.10)    7859 (52.47)    2912 (54.13)  
           
Outcomes           
           
In-hospital mortality Yes   11044 (25.14)    5915 (25.09)    3358 (22.42)    1771 (32.92) <0.0001 
No   32892 (74.86)   17663 (74.91)   11620 (77.58)    3609 (67.08)  
           
LOS greater than 4 days Yes   22732 (52.82)   12536 (53.85)    7647 (52.23)    2549 (49.86) <0.0001 
No   20302 (47.18)   10745 (46.15)    6994 (47.77)    2563 (50.14)  
Missing     902 (2.05)     297 (1.26)     337 (2.25)     268 (4.98)  
           
Independent ambulatory 
status 
Yes   10461 (33.18)    5505 (32.52)    3886 (34.89)    1070 (30.92) <0.0001 
No   21066 (66.82)   11424 (67.48)    7252 (65.11)    2390 (69.08)  
Missing   12409 (28.24)    6649 (28.20)    3840 (25.64)    1920 (35.69)  
           
mRS > 2 (in documented 
patient cohort) 
Yes   22448 (82.87)   12150 (83.49)    7379 (80.46)    2919  (86.75) <0.0001 
No    4640 (17.13)    2402 (16.51)    1792 (19.54)     446  (13.25)  
           
+ Note: P-values were calculated by comparing non-missing row values only; these percents sum to 100%.  The percent of missing row values is informative and 
therefore also presented here for convenience. 
+ P-values are based on Pearson chi-square tests for all categorical row variables. 
* P-values are based on chi-square rank based group means score statistics for all continuous/ordinal row variables (designated by *). 
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* This is equivalent to Kruskal-Wallis tests. 
EMS: emergency medical service; INR: international normalized ratio; LOS: length of stay; NIHSS: National Institute of Health Stroke Scale; mRS: modified 
Rankin Scale; TIA: Transient Ischemic Attack; CAD: coronary artery disease; MI: myocardial infarction; PVD: peripheral vascular disease; HDL: high density 
lipoprotein; LDL: low density lipoprotein; BMI: body mass index; IV rt-PA: intravenous recombinant tissue plasminogen activator.  
  
 
 
 
D
ow
nloaded from
 http://ahajournals.org by on September 7, 2018
 
 
Figure S1a. Study Cohort Development and Exclusions -Acute Ischemic Stroke (AIS).  
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Figure S1b. Study Cohort Development and Exclusions - Intracerebral Hemorrhage (ICH).  
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Figure S2a. Shock Index distribution of the whole sample.  
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Figure S2b. Shock Index distribution of Acute Ischemic Stroke (AIS) Patients.  
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Figure S2c. Shock Index distribution of Intracerebral Hemorrhage (ICH) Patients.  
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Figure S3. Outcomes vs. Shock Index (Shock Index was model as cubic splines) truncated 
at SI value of 1.5 to remove extreme outliers. 
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B. Acute Ischemic Stroke cohort. 
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C. Intracerebral Hemorrhage cohort. 
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Figure S4. Outcomes vs.  Shock Index (Shock Index was model as cubic splines). 
 
A. Overall population (LOS > 4 days vs <= 4 days) 
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B. Acute Ischemic Stroke cohort. 
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C. Intracerebral Hemorrhage cohort. 
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Figure S5. Outcomes vs. Shock Index (Shock Index was model as cubic splines).  
 
A. Overall population 
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B. Acute Ischemic Stroke cohort 
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C. Intracerebral Hemorrhage cohort 
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Figure S6. Outcomes vs.  Shock Index (Shock Index was model as cubic splines).  
 
A. Overall population 
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B. Acute Ischemic Stroke cohort 
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C. Intracerebral Hemorrhage cohort 
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